
Bridgebio Continues Long Term Debt Management Strategy And Announces Proposed Offering Of Convertible Senior Notes
Jan 14 (Reuters) - BridgeBio Pharma Inc (BBIO.O) :
* BRIDGEBIO CONTINUES LONG TERM DEBT MANAGEMENT STRATEGY AND ANNOUNCES PROPOSED OFFERING OF CONVERTIBLE SENIOR NOTES DUE 2033 TO PREFUND REPAYMENT OF CONVERTIBLE SENIOR NOTES DUE 2027
* BRIDGEBIO PHARMA INC - TO OFFER $550 MILLION CONVERTIBLE SENIOR NOTES DUE 2033
* BRIDGEBIO PHARMA INC - PROCEEDS TO REPURCHASE OR REPAY 2027 NOTES Source text: Further company coverage: (BBIO.O)